Synergy between EphA2-ILs-DTXp, a novel EphA2 targeted nanoliposomal taxane, and PD-1 inhibitors in preclinical tumor models
Kamoun, Walid S., Dugast, Anne-Sophie, Suchy, James J., Grabow, Stephanie, Fulton, Ross B, Sampson, James F, Luus, Lia, Santiago, Michael, Koshkaryev, Alexander, Sun, Gang, Askoxylakis, Vasileios, TamLanguage:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-19-0414
Date:
October, 2019
File:
PDF, 3.75 MB
english, 2019